ArticleTranslational oncology2024

Commentary: Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma.

Liusheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.